2024 Program

SATURDAY 31 August 2024

0730 – 1730 Registration Open
Pre ANZSN ASM Courses
Room RIVERBANK 6, 7 & 8 RIVERBANK 5
Meeting Nephrology & Transplantation Update Course KidGen
0830 – 1330 1st Day of the 2 day course.  2024 KidGen Symposium
1330-1730 Combined Nephrology & Transplantation Update Course and KidGen Symposium Plenary Session
1730 – 1900 Nephrology & Transplantation Update Course Networking Event

SUNDAY 1 September 2024RIVERBANK

All sessions are in-person only.

0730 – 1600 Registration Open
0830 – 1900 Pre ANZSN ASM Courses
Room RIVERBANK 2 RIVERBANK 5 RIVERBANK 4 RIVERBANK 7 & 8
Meeting Consumers Day Renal Nutrition Update Kidney Scientists Day Nephrology & Transplantation Update Course
0830

 

0930 2nd Day of the 2 day course. 
1030
1130
1230
1330
1430
1530
1630
1630 – 1830 Research & Career Opportunity Event

MONDAY 2 September 2024

0730 – 1800 Registration Open
0730 – 0815 Arrival Tea & Coffee, Exhibition, Poster Viewing | Exhibition Area
0815 – 0845 Cultural Welcome | Adelaide Convention Centre Plaza

Performed by Ngangki Warra

Ngangki Warra is a Kaurna female led cultural collective that aims to elevate and amplify the voices of women and magnify the existence of the Matriarchy on Kaurna Yarta. Ngangki Warra’s core values are to continue caring for and protecting our language, culture and country.

We ask that all delegates be gathered on the Convention Centre Plaza in advance of the cultural welcome commencing at 8.15am.
If you arrive late, please discreetly join the back of the audience so as not to interrupt the ceremony. Photography and videography is permitted.

0845 – 1000 PLENARY #1: ASM Opening
Room HALL D
Session Chair Professor Rathika Krishnasamy
0845 – 0900 Welcome to the ASM  & President’s Address: Associate Professor Rathika Krishnasamy
0900 – 1000 Plenary Speaker: Associate Professor Karin Gerritsen, University Medical Center Utrecht, Netherlands

INNOVATIONS IN KIDNEY REPLACEMENT TECHNOLOGY AND SUSTAINABILITY

1000 – 1030 Morning Tea, Exhibition, Poster Viewing | Exhibition Area – Foyer E
1030 – 1200 CONCURRENT SESSION #1
Room HALL D HALL A HALL B RIVERBANK 2&3
Stream Early Career
Award Session
Consumer Symposium Nutrition & Microbiome Symposium
Tech, Wearables & Sustainability Symposium
Session Chairs Grahame Elder & Sonia Saad Chandana Guha & Nicole Scholes-Robertson  Jessica Dawson & Adam Mullan Jason Wei & Sadia Jahan
1030 – 1045 EFFECT OF DECEASED DONOR TYPE ON KIDNEY RECIPIENT POST-TRANSPLANT HEALTH SERVICE UTILIZATION
Nicholas Chan
VOICES THAT MATTER: CONSUMER ENGAGEMENT IN PARENTHOOD AND KIDNEY DISEASE

Erandi Hewawasam, Amanda Sluiter

Pregnancy Kidney Research Australia

GUT MICROBIOME IN CKD
Professor I-Wen Wu, Taipei Medical University Hospital, Taiwan
WATER USAGE IN HD / STERILIZATION TECHNIQUES
Dr Shaundeep Sen, Concord Repatriation General Hospital
1045 – 1100 INVESTIGATING THE ROLE OF TNFAIP3 VARIATION IN KIDNEY DISEASE
Ananya Deshpande
ESTABLISHING THE ANZDATA ADVISORY PANEL

Jasmin Mazis, Stephen Shirley

ANZDATA Consumer Advisory Panel


LAUNCH OF BEAT-CKD IMPACT TRAINING

Anastasia Hughes

1100 – 1115 EFFECT OF HAEMODIAFILTRATION OR HAEMODIALYSIS ON POSTOPERATIVE MORTALITY IN PATIENTS WITH KIDNEY FAILURE
Dharmenaan Palamuthusingam
AKCTION – ABORIGINAL KIDNEY CARE TOGETHER IMPROVING OUTCOMES NOW

Jared Kartinyeri, Janet Kelly

MICROBIOTA IN CKD
Dr Jihyun Yang, Sungkyunkwan University Kangbuk Samsung Hospital 
CARING FOR COUNTRY AND HEALTH
Keenan Smith, ElectraNet / Wirangu Aboriginal Corporation
1115 – 1130 TEMPORAL CHARACTERISATION OF RENAL IMMUNOPHENOTYPE WITH MITOCHONDRIAL KINETIC PROFILE IN A PRECLINICAL MODEL OF DIABETIC KIDNEY DISEASE
Inez Trambas
KIDNEY HEALTH AUSTRALIA
1130 – 1145 SINGLE-ARM PROSPECTIVE STUDY OF DOSING AND TOLERABILITY OF CANNABIDIOL IN PEOPLE WITH SYMPTOMS ASSOCIATED WITH KIDNEY FAILURE
Brendan Smyth
CONSUMER DAY WORKSHOP FEEDBACK PANEL

Jasmin Mazis, Dale Coghlan, Shyamsundar Muthuramalingam, Kelli Owen and Brooke Huuskes

THE IMPACT OF DIETARY INTERVENTIONS ON THE GUT MICROBIOME IN CHRONIC KIDNEY DISEASE
Dr Annabel Biruete, Purdue University and Indiana University School of MedicineVIRTUAL PRESENTATION
WEARABLE TECHNOLOGIES FOR DIALYSIS
Associate Professor Karin Gerritsen, University Medical Center Utrecht, Netherlands
1145 – 1200
1200 – 1300 Lunch, Exhibition, Poster Viewing | Exhibition Area – Foyer E
1300 – 1500 PLENARY #2: Young Investigator Award Session
Room HALL D
Session Chairs  Matthew Jose & Jacqueline Phillips
1300 – 1315 DIRECT COST OF CATHETER-RELATED BLOODSTREAM INFECTION AMONG HOSPITALISED HAEMODIALYSIS-DEPENDENT PATIENTS IN AUSTRALIA: EVIDENCE FROM A DATA LINKAGE STUDY
Jayson Catiwa
1315 – 1330 HIGH-RESOLUTION SPATIAL TRANSCRIPTOMICS REVEALS SEGMENT-SPECIFIC PATHWAYS OF TUBULAR FERROPTOSIS IN THE TRANSITION FROM ACUTE TO CHRONIC KIDNEY DISEASE
Benjamin Adams
1330 – 1345 SODIUM MAGNETIC RESONANCE IMAGING TO ASSESS TISSUE SODIUM CONCENTRATIONS IN THE CKD POPULATION
Kylie Martin
1345 – 1400 ANGIOTENSIN II TYPE 2 RECEPTOR AGONISM WITH N-Ac-β-Pro7Trp8AngIII IS PROTECTIVE IN MITIGATING DIABETES-ASSOCIATED RENAL AND CARDIOVASCULAR DYSFUNCTION
Daniel Ford-Learner
1400 – 1415 HAEMODIALYSIS VASCULAR ACCESS PROCEDURE RATE IN AOTEAROA NEW ZEALAND: A DATA LINKAGE ANALYSIS
Kate Richards
1415 – 1430 DRUG REPURPOSING IN THE CONTEXT OF ACUTE KIDNEY INJURY
Aadhar Moudgil
1430 – 1445 QUALITY OF CHRONIC KIDNEY DISEASE CARE IN AUSTRALIAN PRIMARY CARE: ANALYSIS OF A NATIONAL GENERAL PRACTICE DATASET
Hannah Wallace
1445 – 1500 IPSC-DERIVED KIDNEY ORGANOIDS OUTPERFORM ADULT-STYLE TUBULOIDS IN MODELLING THE PROXIMAL TUBULE
Ana Nunez-Nescolarde
1500 – 1530 Afternoon Tea, Exhibition, Poster Viewing | Exhibition Area – Foyer E
1530 – 1700 CONCURRENT SESSION #2
Room HALL D HALL A HALL B RIVERBANK 2&3
Stream Kidney Health Australia (KHA)
Award Session
Mini Orals: General Nephrology – Glomerulonephritis & Cystic Kidney Disease Mini Orals: General Nephrology – Other Genomics & Genetics Symposium
Session Chair Eoin O’Sullivan & Nicole Scholes-Robertson Simon Jiang & Melinda Tee Patrick Manley & Monica Ng Hugh McCarthy & Julia Jefferis
1530 – 1545 NAVKIDS2: A RANDOMISED CONTROLLED TRIAL OF A PATIENT NAVIGATOR PROGRAM IN CHILDREN WITH CHRONIC KIDNEY DISEASE
Chandana Guha
PATIENT’S PERSPECTIVES ON LIVING WITH PRIMARY MEMBRANOUS NEPHROPATHY: A SEMI-STRUCTURED INTERVIEW STUDY
Edmund Chung
A SYSTEMATIC REVIEW OF THE COMPARATIVE PROGNOSTIC ACCURACY OF AGE-SPECIFIC ESTIMATED GLOMERULAR FILTRATION RATE EQUATIONS IN OLDER ADULTS
Elisa Bongetti
HYPOKALEMIA, BUT (MAYBE) NOT AS YOU KNOW IT
Professor Fiona Karet, University of Cambridge, UK
BAFF-EXPRESSING CHIMERIC ANTIGEN RECEPTOR T-CELLS SPECIFICALLY ELIMINATE B-CELLS IN-VITRO
Edmund Chung
PATIENT AND CAREGIVER INVOLVEMENT IN IMPLEMENTING RESEARCH IN CHRONIC KIDNEY DISEASE: A NATIONAL WORKSHOP
Dale Coghlan
1545 – 1600 THE CUMULATIVE INCIDENCE AND RISK FACTORS FOR CHRONIC KIDNEY DISEASE IN YOUNG ABORIGINAL PEOPLES: THE ARDAC STUDY
Amandi Hiyare Hewage
THERAPEUTIC DRUG MONITORING OF MYCOPHENOLATE MOFETIL USING A LIMITED SAMPLING STRATEGY IN PATIENTS WITH LUPUS NEPHRITIS: AN AUSTRALIAN SINGLE CENTRE EXPERIENCE
Aleksandra Djordjevic
CONSUMER INVOLVEMENT IN RESEARCH IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW
Dale Coghlan
DIET IN THE MANAGEMENT OF NON-DIALYSIS DEPENDENT POLYCYSTIC KIDNEY DISEASE (PKD): PERCEPTIONS AND EXPERIENCES OF PATIENTS LIVING WITH PKD
Stephanie Notaras
MAGNETIC RESONANCE SPECTROSCOPY IN CHRONIC KIDNEY DISEASE: THE DISCERN-CKD STUDY
Tyrone Humphries
1600 – 1615 INCREMENTAL PERITONEAL DIALYSIS – A RANDOMISED CONTROLLED STUDY
Louis L Huang
CLINICAL FACTORS INFLUENCING CORTICOSTEROID INITIATION PRIOR TO KIDNEY BIOPSY IN GLOMERULONEPHRITIS
Peter-Joon Lee
POST-OPERATIVE OUTCOMES IN PATIENTS WITH  KIDNEY FAILURE RECEIVING CHRONIC KIDNEY REPLACEMENT THERAPY AFTER GYNAECOLOGICAL SURGERY: A BI-NATIONAL DATA LINKAGE STUDY
Mina Khair
GENETIC VARIATION IN AQUAPORINS AND PRECISION DIALYSIS
Professor Olivier Devuyst, University of Zurich, Switzerland
BILATERAL SEROUS RETINAL DETACHMENT AS A PRESENTING SIGN OF MEMBRANOUS NEPHROPATHY – A CASE REPORT
Natasha C Muthukrishna Griffiths
OUTCOMES OF EARLY ANTIVIRAL TREATMENT IN AMBULATORY COVID -19 END STAGE KIDNEY DISEASE PATIENTS- AN OBSERVATIONAL, SINGLE-CENTRE EXPERIENCE
Chui Lynn Lai
1615 – 1630 PREGNANCY-RELATED ACUTE KIDNEY INJURY: A MULTI-JURISDICTIONAL DATA-LINKAGE STUDY ON KIDNEY REPLACEMENT THERAPY NEED
Arunima Jain
OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND PROTEINURIA: A MULTI CENTRE COHORT STUDY
Arushi Ramnarain
PATIENT-REPORTED OUTCOME MEASURES FOR LIFE PARTICIPATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW
Anastasia Hughes
ANCA-ASSOCIATED VASCULITIS WITH RENAL INVOLVEMENT IN THE AUCKLAND REGION
Saiprasad Ravi
REPORTING THE INVOLVEMENT OF PATIENTS AND CAREGIVERS IN IDENTIFYING AND DESIGNING INTERVENTIONS FOR HEALTH RESEARCH: THE IDEAS FRAMEWORK
Javier Recabarren
1630 – 1645 ‘TRANSPLANT TINDER’ – HOW EASY WILL IT BE TO FIND YOUR PERFECT (HLA) MATCH?
Rowena Lalji
PERFORMANCE OF ANCA KIDNEY RISK SCORE FOR PREDICTING RENAL OUTCOME IN A NEW ZEALAND COHORT
Saiprasad Ravi
PATIENT REPORTED OUTCOME AND EXPERIENCE MEASURES IN CHILDREN AND ADOLESCENTS WITH CHRONIC KIDNEY DISEASE: A SCOPING REVIEW
Angela Rejuso
NORFOLK ISLAND HEALTH STUDY- THE MUTINY ON THE BOUNTY’S ROLE IN GENETICS RESEARCH
Distinguished Professor Lyn Griffiths, Queensland University of Technology 
GLOMERULAR MONOCLONAL GAMMOPATHIES IN WESTERN AUSTRALIA, STATE-WIDE 5-YEAR RETROSPECTIVE ANALYSIS
Awf Abdulrahman Shaban
IDENTIFICATION OF PAPP-A2 AS A CIRCULATING FACTOR ASSOCIATED WITH RENAL GROWTH FOLLOWING A NEPHRECTOMY
Darling Rojas-Canales
1645  1700 THE IMPACT OF SEX AND INTERSECTIONAL DISADVANTAGE ON ACCESS TO TRANSPLANT FOR PATIENTS WITH KIDNEY FAILURE
Melanie Wyld
PROTEOMIC INSIGHTS LINK SUGT1 AND Nek8 TO CYST FORMATION IN NEPHRONOPHTHISIS
Jacqueline K Phillips
UPDATE THIAZIDE DIURETIC EVIDENCE REVIEW FOR CARI GUIDELINES KIDNEY STONES RECOMMENDATIONS
David Tunnicliffe
Mini Oral buffer  Mini Oral buffer 
1700 – 1800 ANZSN AGM | HALL A
1730 – 2000 Welcome Reception | Exhibition Area, Adelaide Convention Centre
Featuring a performance from the Kapula Choir (Kidney Choir) 
1930 – 2130 yANZSN Networking Event | Foyer A & B, Adelaide Convention Centre

TUESDAY 3 September 2024

0700 – 0830 Breakfast Symposiums
Room Riverbank Room 2 Riverbank Room 3
  Bayer Breakfast Symposium

Beyond CKD Progression: An approach to CardioRenal management in CKD and T2D

Join us for an interactive session to discuss the latest developments & pathways in the holistic management of CKD & T2D.

Otsuka Breakfast Symposium

The evolving future treatment landscape for IgA Nephropathy


Dr Kate Robson, Monash University

Professor Brad Rovin, Ohio State University Wexner Medical Centre

View Full  Program Here

0815 – 1700 Registration Open
0815 – 0845 Arrival Tea & Coffee, Exhibition, Poster Viewing | Exhibition Area
0845 – 1000 PLENARY #3: Plenary Speaker
Room HALL D
Session Chair Kelli Owen & Samantha Bateman
0845 – 0900 Day 2 Welcome
0900 – 1000 Plenary Speaker: Professor Caroline Tait, Canada Research Chair, Tier 1 Indigenous Health Inequities and Inclusion, Citizen Metis Nation-Saskatchewan

ORGAN DONATION AND TRANSPLANTATION INEQUITIES IN SETTLER COLONIAL COUNTRIES: WHY DOES LOCAL TO INTERNATIONAL MOBILIZATION BY INDIGENOUS PEOPLE MATTER?

1000 – 1030 Morning Tea, Exhibition, Poster Viewing | Exhibition Area
1030 – 1200 CONCURRENT SESSION #3
Room HALL D HALL A HALL B RIVERBANK 2&3
Stream Shaun Summers Clinical Trainee
Award Session
– supported by gold sponsors CSL Seqirus, AMGEN & Pharmacor
Mini Orals: Nutrition, Haemodialysis – CKD-MBD/Anaemia/Adequacy – Other – Vascular Access Mini Orals: Indigenous Health Advancement, Paediatrics Discovery & Translational Science
Award Session
– supported by gold sponsors CSL Seqirus, AMGEN & Pharmacor
Session Chairs Melanie Wyld & Richard Kitching Anthony Meade & Anna Francis Jaqui Hughes & Chanel Prestidge Rob Walker & Jantina Manning
1030 – 1045 PATTERNS OF READMISSION AND DEATH AFTER AKI: A STATEWIDE DATA-LINKAGE STUDY
Zena Barakat
A CORE OUTCOME SET FOR TRIALS IN CHRONIC KIDNEY DISEASE: REPORT OF THE STANDARDIZED OUTCOMES IN NEPHROLOGY – CHRONIC KIDNEY DISEASE (SONG-CKD) STAKEHOLDER WORKSHOPS
Andrea Matus
PREFORMED DIALYSIS ACCESS FOR ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE: WE CAN DO BETTER
Samantha Bateman
MODELLING HYPOXIC INJURY AND MALADAPTIVE REPAIR IN HUMAN KIDNEY ORGANOIDS
Alex Combes
DOSING, EFFICACY AND SAFETY OF RITUXIMAB FOR THE TREATMENT OF MINIMAL CHANGE DISEASE IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Sanjana Dang
OUTCOMES FOR CLINICAL TRIALS INVOLVING ADULTS WITH CHRONIC KIDNEY DISEASE: A MULTINATIONAL DELPHI SURVEY INVOLVING PATIENTS, CAREGIVERS AND HEALTH PROFESSIONALS
Andrea Matus
HOW PATIENT NAVIGATORS CAN IMPROVE PATIENT JOURNEYS FOR ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE WITH KIDNEY FAILURE: THE COMPASS PROJECT
Kelli Owen, Isabelle Haklar
1045 – 1100 A PROGNOSTIC TOOL TO ASSIST THE DECISION OF CHRONIC DIALYSIS VS BEST SUPPORTIVE CARE – JUST BECAUSE YOU CAN DOESN’T MEAN YOU SHOULD
Rachel Frederick
A PILOT RANDOMISED CROSSOVER TRIAL OF ANGIOTENSIN II FOR THE PREVENTION AND TREATMENT OF MUSCLE CRAMPS IN MAINTENANCE HAEMODIALYSIS PATIENTS: THE CRAMP HD STUDY
Emily See
FLIPPING THE SCRIPT: ADDRESSING CULTURAL IMBALANCES IN FIRST NATIONS KIDNEY RESEARCH
Rhanee Lester
FROM DISCOVERY TO TREATMENT OF ITK AUTOIMMUNITY
Simon Jiang
LONG-TERM EFFECT OF INCREASING WATER INTAKE ON CHRONIC PAIN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Sumedh Jayanti
FGF23 AND SARCOPENIA IN MAINTENANCE DIALYSIS POPULATION
Limy Wong
PRIORITISING INDIGENOUS VOICES & STORIES IN KIDNEY RESEARCH – THE TOP END MEDICINAL IRON RESEARCH & STUDY ADVISORY GROUP
Stephanie Long
1100 – 1115 EARLY TO MID PREGNANCY RENAL PARAMETERS AND ADVERSE PREGNANCY OUTCOMES IN WOMEN WITH EARLY STAGE CKD
Alessandra Orsillo
ANTICOAGULATION IN A HAEMODIALYSIS COHORT; A SINGLE CENTRE REVIEW
Aditya Patil
PREVALENCE OF MARKERS OF LIVER DISEASE AND ASSOCIATION WITH HYPERFERRITINAEMIA IN FIRST NATIONS PATIENTS ON MAINTENANCE HAEMODIALYSIS FROM THE NORTHERN TERRITORY OF AUSTRALIA: A SUB-STUDY OF INFERR CLINICAL TRIAL
Sandwana William Majoni
REDUCED BLOOD FLOW TO THE KIDNEY IN DIABETIC RATS INDUCES ACUTE KIDNEY INJURY VIA METABOLIC DYSFUNCTION AND OXIDATIVE STRESS
David Nikolic-Paterson
TOWARD ZERO DEATHS DUE TO DIALYSIS VASCULAR ACCESS HAEMORRHAGE
Evelyn Perry
CHANGE IN KIDNEY FUNCTION PRIOR TO COMMENCING HAEMODIALYSIS – IS UNEXPECTED DECLINE A COMMON REASON FOR LACK OF PREPARATION?
Aharon Golod
HIDDEN FIGURES: ARE WE LOOKING AT THE RIGHT METRICS FOR TRANSPLANT ACCESS
Stephen McDonald
1115 – 1130 IDENTIFICATION OF A NOVEL GAIN OF FUNCTION IRF5 MUTATION IN AUTOIMMUNITY
Geetha Raman
A NOVEL TOOL FOR THE DETECTION OF NEEDLE FEAR IN PRE-DIALYSIS AND DIALYSIS PATIENTS – MEASURING NEEDLE FEAR (MNF) TOOL
Shilpanjali Jesudason
AN ELECTRONIC MEDICAL RECORD AUDIT OF URINARY TRACT INFECTION FOLLOWING MICTURATING CYSTOURETHROGRAM IN THE NEONATAL INTENSIVE CARE UNIT
Thomas Forbes
NOVEL THERAPY THAT SELECTIVELY TARGETS NEUTROPHIL EXTRACELLULAR TRAPS ATTENUATES INFLAMMATION AND KIDNEY INJURY IN EXPERIMENTAL ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY VASCULITIS
Kim Maree O’Sullivan
DIAGNOSING X LINKED ALPORTS IN PAEDIATRIC PATIENTS ENABLES RETROSPECTIVE DIAGNOSIS IN UNKNOWINGLY AFFECTED PARENTS
Matthew Vitalone
A FLOW PROFILE – MODELLING PHYSIOLOGIC BLOOD FLOW IN ARTERIOVENOUS FISTULAS FOR USE IN MACROFLUIDIC SYSTEMS
Nasir Shah
SCHOOL-BASED SCREENING FOR HIGH BLOOD PRESSURE IN CHILDREN IS EFFECTIVE, ACCEPTABLE AND FEASIBLE
Jonathan Glenning
1130 – 1145 PRINTCISION MEDICINE: A RE-USEABLE, 3D-PRINTED, PATIENT-SPECIFIC IN VITRO MODEL OF ARTERIOVENOUS FISTULAS FOR ENDOTHELIAL CELL STUDIES
Nasir Shah
PERSPECTIVES OF CAREGIVERS ON ACCESS TO HEALTHCARE FOR CHILDREN WITH CHRONIC KIDNEY DISEASE: A SEMI-STRUCTURED INTERVIEW STUDY
Chandana Guha
THROMBOSPONDIN-1 IS IMPLICATED IN DRIVING RENAL OSTEODYSTROPHY IN CKD
Natasha Rogers
DOES DIETARY PHOSPHORUS INTAKE DIFFER BETWEEN DIALYSIS AND NON-DIALYSIS DAYS? USING MULTIPLE PASS METHODOLOGY TO PROVIDE THE ANSWER
Joanne Beer
KIDNEY TRANSPLANT BIOPSY ADEQUACY AND OUTCOMES IN CHILDREN
Sarah Marokakis
1145 – 1200 RELIABILITY, REPRODUCIBILITY AND AGREEMENT BETWEEN PRE DIALYSIS VS MID DIALYSIS HAND GRIP STRENGTH MEASUREMENT
Anne Snelson
GLOMERULAR BASEMENT MEMBRANE MORPHOLOGY IN CHILDREN WITH IGA NEPHROPATHY
Hugh J McCarthy
URINARY EXTRACELLULAR VESICLES AS PROGNOSTIC BIOMARKERS OF TUBULAR FERROPTOSIS IN ACUTE KIDNEY INJURY PROGRESSION
Andrew Kassianos
Mini Oral buffer  Mini Oral buffer 
1200 – 1400 Lunch, Exhibition, Poster Viewing | Exhibition Area
1230 – 1310 Poster Viewing Session 1

Assigned authors to stand by posters to answer questions

 

1315-1355 Poster Viewing Session 2

Assigned authors to stand by posters to answer questions

1400 – 1500 PLENARY #4: Plenary Speaker
Room HALL D
Session Chair Professor Andrew Mallet
1355 – 1500 Plenary Speaker: Professor Fiona Karet, University of Cambridge, UK

WALKING THE WALK: RENAL GENETIC EVOLUTIONARY STORIES

1500 – 1530 Afternoon Tea, Exhibition, Poster Viewing | Exhibition Area
1530 – 1700 CONCURRENT SESSION #4
Room HALL D HALL A HALL B RIVERBANK 2&3
Stream First Nations & Indigenous Health Symposium Mini Orals: Interventional Nephrology, Transplantation Mini Orals: General Nephrology – Pregnancy associated, Peritoneal Dialysis, Quality Indicators, Environmental Sustainability yANZSN Mentoring Symposium
Session Chair Kelli Owen & Samantha Bateman Catherine Wilkinson & Andrew Sunderland Jordan Li & Alessandra Orsillo Matthew Rowlandson & Lucy McMullen
1530 – 1545 BUILDING INDIGENOUS COLLECTIVE INTELLIEGENCE IN ORGAN DONATION AND TRANSPLANTATION MEDICINE
Professor Caroline Tait, University of Calgary, Canada
OPTIMAL NEEDLE SIZE FOR RENAL TRANSPLANT BIOPSY: A RETROSPECTIVE SINGLE CENTRE STUDY
Jocelyn Shan
HOSPITAL ADMISSIONS DURING THE FIRST 10-YEARS OF LIFE IN CHILDREN BORN TO KIDNEY TRANSPLANTED MOTHERS
Erandi Hewawasam
BUILDING A SUCCESSFUL CAREER IN RESEARCH AND LEADERSHIP
Professor Steve Wesselingh, National Health and Medical Research Council
IDENTIFYING FACTORS LINKED TO NON-TRANSPLANTATION IN THE DIABETIC KIDNEY DISEASE POPULATION IN TARANAKI, NEW ZEALAND – A 10 YEAR AUDIT
David Thompson
HYPERTENSION IN PREGNANCY GUIDELINE – UPDATED 2024- A SYSTEMATIC REVIEW, META-ANALYSIS AND THE DEVELOPMENT OF EVIDENCE BASED RECOMMENDATIONS
Angela Makris
1545 – 1600 ACCESS TO KIDNEY TRANSPLANT WAITLISTING FOR PEOPLE WITH MENTAL ILLNESS; A COHORT STUDY IN NSW
Angela Webster
INCIDENCE OF PREECLAMPSIA AND HYPERTENSIVE DISORDERS IN PREGNANCY AMONGST AUSTRALIAN ABORIGINAL WOMEN: THE ARDAC STUDY
Jacqueline H Stephens
Demonstrating capability in culturally safe kidney clinical care – CARI GUIDELINE and AHPRA Cultural safety National Law

Prof Jaqui Hughes

DECISION SUPPORT TOOL TO AID RISK ASSESSMENT OF ACCEPTING VERSUS DECLINING A KIDNEY OFFER FROM A DONOR WITH A RISK OF DISEASE TRANSMISSION
Angela Webster
ASSISTED PERITONEAL DIALYSIS PROGRAM USING NON-REGISTERED NURSE HEALTHCARE STAFF
Paul Bennett
1600 – 1615 NON-RETRIEVAL AND NON-UTILISATION OF DECEASED DONOR KIDNEYS FOR TRANSPLANTATION: AN AUSTRALIAN COHORT STUDY
Rachel Cutting
MICROBIOLOGY OF PROCEDURE RELATED PD-PERITONITIS FOLLOWING GASTROSCOPY AND COLONOSCOPY: A BINATIONAL DATA-LINKAGE STUDY
Shaun Chandler
WELLNESS-CENTERED LEADERSHIP: FLOURISHING AS LEADER
Dr Sarah Dalton, Capstan Partners
Placed based cultural safety training – the importance of culture for health and wellbeing 

Kelli Owen

 

IMPLEMENTATION AND EVALUATION OF A COMPREHENSIVE RENAL TRANSPLANTATION PREHABILITATION ALLIED HEALTH MODEL OF CARE
Suzannah Jackson
FREQUENCY OF THERAPY ALERTS DURING THE FIRST 30 DAYS OF AUTOMATED PERITONEAL DIALYSIS AND ITS RELATIONSHIP TO TECHNIQUE SURVIVAL
Annie Conway
1615 – 1630 SEX AND GENDER AS PREDICTORS FOR ALLOGRAFT AND PATIENT-RELEVANT OUTCOMES AFTER KIDNEY TRANSPLANTATION: A PROGNOSTIC REVIEW
Sumedh Jayanti
TEMPORAL ASSOCIATION OF PERITONEAL DIALYSIS PERITONITIS RATES AND OUTCOMES WITH COVID-19 PANDEMIC ONSET IN AUSTRALIA: A REGISTRY ANALYSIS
Arunima Jain
LIVING DONOR DEMOGRAPHICS IN AUSTRALIA: HAVE DISPARITIES INCREASED OVER TIME?
Rose-marie Scarlato
COST ANALYSIS OF EARLY START PERITONEAL DIALYSIS VERSUS HAEMODIALYSIS
Keiren Pirabhahar
1630 – 1645 Small group discussions around sharing learnings, ideas and strategies to decolonise our practice, research and education and advocate for First Nations health within our organisations.

 

PERSPECTIVES AND EXPERIENCES OF WOMEN WITH A KIDNEY TRANSPLANT ON ACCESS TO HEALTHCARE- AN INTERNATIONAL QUALITATIVE STUDY
Nicole Scholes-Robertson
EXPLORING THE ASSOCIATION OF SEX/GENDER DISPARITIES WITH ALL-CAUSE AND CAUSE-SPECIFIC PERITONEAL DIALYSIS DISCONTINUATION: A MULTIPLE MEDIATION ANALYSIS
Dharshana Sabanayagam
Panel Discussion:
NAVIGATING LEADERSHIP, QUALITY IMPROVEMENT AND MENTORING IN KIDNEY CARE
Professor Steve Wesselingh, Dr Sarah Dalton, Dr Samantha Ng, Professor Vlado Perkovic
A MULTI-NATIONAL SURVEY ON CURRENT PRACTICE, BARRIERS AND NEEDS FOR IMPLEMENTING MYCOPHENOLATE DOSE OPTIMIZATION IN KIDNEY TRANSPLANTATION
Sonia Sharma
CONSUMER-PRIORITISED QUALITY INDICATOR OUTCOMES IN KIDNEY FAILURE CARE
Christopher Davies
1645 – 1700 Wrap up and Close

 

IMPLEMENTATION OF THE VIRTUAL CROSSMATCH (VXM) IN AUSTRALIA FOR DECEASED DONORS AND KIDNEY TRANSPLANT WAITLIST RECIPIENTS
Narelle Watson
SAVING WATER, REDUCING WASTE: A COMPARATIVE STUDY OF INCREMENTAL VERSUS STANDARD DOSE PERITONEAL DIALYSIS ON WATER, DIALYSIS WASTE AND CARBON EMISSIONS
Mary Ann Nicdao
Mini Oral buffer  Mini Oral buffer 
1900 till late Gala Dinner | HALLS J-K, Adelaide Convention Centre

WEDNESDAY 4 September 2024

0715 – 0830 Clinical Update
Room Riverbank 2 & 3
Novo Nordisk Clinical Update 

Navigating the Future of Diabetic Kidney Disease: Unveiling New Horizons and Patient-Centric Approaches

Join Prof Carol Pollock and Prof Meg Jardine for breakfast, coffee and an engaging scientific exchange as they delve into the latest advancements in the management of Diabetic Kidney Disease. This event will feature insightful discussions on clinical updates, emerging therapies, patient perspectives, and a look at the future landscape. Our esteemed speakers will illuminate new horizons, address patient-centric concerns, and explore the evolving paradigms in diabetic kidney disease management.

0830 – 1700 Registration Open
0830 – 0900 Arrival Tea & Coffee, Exhibition, Poster Viewing | Exhibition Area
0900 – 1030 CONCURRENT SESSION #5
Room HALL D HALL A HALL B RIVERBANK 2&3
Stream ANZDATA Symposium Mini Orals: Health Services Research, General Nephrology – Epidemiology and Public Health Mini Orals: Experimental Immunology, General Nephrology – Acute kidney injury,  Experimental Tubulointerstitial Disease Mineral & Bone Metabolism in Kidney Disease Symposium
Session Chair Stephen McDonald & Kate Richards Angela Webster & Megan Brown Kim O’Sullivan & Sih Min Tan Carmel Hawley & Meg Jardine
0900 – 0915

ANZDATA UPDATE
Associate Professor Nicholas Gray, Sunshine Coast University Hospital


DIALYSIS CAPACITY REPORT
Dr Eric Au, Alfred Health / ANZDATA Registry


OUTCOMES FOR LIVING KIDNEY DONORS FOLLOWING DONOR NEPHRECTOMY IN AOTEAROA NEW ZEALAND: A 30-YEAR RETROSPECTIVE COHORT STUDY
Dr Lai Wan Chan, Waikato Hospital


THE SURVIVAL BENEFIT OF KIDNEY TRANSPLANTATION FOR ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE
Dr Samantha Bateman, Royal Adelaide Hospital & Kelli Owen,Niktt & Compass


ASSOCIATION BETWEEN LIVING DONOR TRANSPLANT RATES AND PERFORMANCE ON 6-MONTH TRANSPLANT QUALITY INDICATOR
Dr Sadiul Kabir, Sunshine Coast University Hospital

THE USE OF TELEHEALTH IN MANAGING PATIENTS WITH CHRONIC KIDNEY DISEASE: THOUGHTS AND PERSPECTIVES OF NEPHROLOGISTS
Brooke Huuskes
RELB MUTATIONS AND A MODEL OF NEPHRITIS
Justin Chan Hsian Loon
TACKLING KIDNEY AGING: FOCUS ON KLOTHO PRESERVATION
Dr María D Sánchez-Niño, ERA Ambassador, IIS-Fundacion Jimenez Diaz & Universidad Autonoma MadridVIRTUAL PRESENTATION
DOES ROUTINE EGFR REPORTING ADVERSELY AFFECT MEDICATION DOSING IN THE ELDERLY?
Gina Davis
DELETERIOUS RELA VARIANTS IN AUTOIMMUNITY
Morgan Downes
0915 – 0930 THE YALATA KIDNEY HEALTH FESTIVAL: IMPLEMENTING CARI CLINICAL AND CULTURAL SAFETY GUIDELINES IN A REMOTE COMMUNITY
Janet Kelly
EXPLORING THE IMPACT OF INTERLEUKIN-37 ON PRO-INFLAMMATORY PATHWAYS IN TWO MODELS OF KIDNEY DISEASE
Jemma Gasperoni
ABORIGINAL KIDNEY CARE TOGETHER -IMPROVING OUTCOMES NOW (AKCTION): PROCESSES, REALITIES AND BENEFITS OF FIRST NATIONS LED RESEARCH
Janet Kelly
RARE LYN AND BLK VARIANTS ACT IN EPISTASIS TO CAUSE HUMAN AUTOIMMUNITY
Sonia Nambadan
0930 – 0945 VACCINE HESITANCY IN RENAL PATIENTS IN SOUTH-WESTERN SYDNEY
Sneha Amin
THE URAF AKI TOOL. A NOVEL, SIMPLE 6-POINT KPI FOR AKI WORKUP AND FOLLOW UP
Samantha Taveras
CHRONIC KIDNEY DISEASE AND BONE HEALTH; ‘MIND THE GAP’
Professor Grahame Elder, Westmead Hospital
THE ASSOCIATION BETWEEN URINE ALBUMIN AND ESTIMATED GLOMERULAR FILTRATION RATE WITH INCIDENT FRAILTY IN HEALTHY OLDER ADULTS: SECONDARY ANALYSIS OF THE ASPREE TRIAL COHORT
Elisa Bongetti
LONG-TERM KIDNEY OUTCOMES OF CRITICALLY ILL PATIENTS WITH COVID-19-ASSOCIATED ACUTE KIDNEY INJURY
Emily See
0945 – 1000 IMPACT OF THE CKD-EPI 2021 EQUATION ON THE CLASSIFICATION OF CKD IN OLDER AUSTRALIAN ADULTS
Elisa Bongetti
CASE OF RENAL HYPOURICEMIA WITH A HOMOZYGOUS MUTATION IN THE SLC22A12 GENE AND LITERATURE REVIEW
Lan Wang
IDENTIFYING THE KIDNEY HEALTH COMMUNITIES’ PRIORITIES FOR UPDATED EVIDENCE-BASED GUIDANCE
Brydee Cashmore
INTERVENTION WITH AN NLRP3 INHIBITOR DOES NOT PREVENT CARDIOVASCULAR AND CYSTIC BURDEN IN A PRE-CLINICAL MODEL OF POLYCYSTIC KIDNEY DISEASE
Emily Major
1000 – 1015 OPTIMISING PRIMARY CARE REFERRALS TO NEPHROLOGY SERVICES BASED ON RISK STRATIFICATION (KFRE)
Clyson Mutatiri
UNLOCKING THE TRANSCRIPTOMIC JOURNEY OF A GROWING KIDNEY, ONE CELL AT A TIME
Soon Wei Wong
CROSSTALK BETWEEN BONE AND MUSCLE
Dr Limy Wong, Eastern Health
A BROAD EPIDEMIOLOGICAL DESCRIPTION OF DIALYSIS PRACTICE CHANGES DURING THE COVID-19 PANDEMIC IN AUSTRALIA AND NEW ZEALAND
Daniela Potter
CONSIDERING URINARY VOLATILE ORGANIC COMPOUNDS AS A NOVEL SOURCE FOR NON-INVASIVE DIAGNOSIS OF TUBULOINTERSTITIAL DISEASE?
Henry H L Wu
1015 – 1030 Q&A Panel Discussion
QUALITY ASSESSMENT OF SHORT VIDEOS ABOUT CHRONIC KIDNEY DISEASE ON SOCIAL MEDIA PLATFORMS – A CROSS-SECTIONAL STUDY
Krupa Shah – VIRTUAL PRESENTATION
INCREASED SEVERITY OF ACUTE KIDNEY INJURY IN OBESE MICE
Chathri Ratnayake – VIRTUAL PRESENTATION
Mini Oral buffer  Mini Oral buffer 
1030 – 1100 Morning Tea, Exhibition, Poster Viewing | Exhibition Area
1100 – 1230 CONCURRENT SESSION #6
Room HALL D HALL A HALL B RIVERBANK 2&3
Stream AKTN/CARI Symposium Mini Orals: General Nephrology – Diabetes/Cardiovascular/Hypertension Models of Care Symposium Contemporary Kidney Disease Treatment Symposium
Session Chair Matthew Roberts & David Tunnicliffe Sradha Kotwal & Grant Luxton Brendan Smyth & Rachael Kermond Drew Henderson & Helen Eddington
1100 – 1115 AKTN Trials Update

THE GOAL TRIAL (FRAILTY IN CKD)
Dr Benignus Logan, University of Queensland

THE VALID STUDY (VASCULAR ACCESS)
Associate Professor Andrea Viecelli, Princess Alexandra Hospital


Implementation Joint Session

BEST FLUIDS: CONSIDERING IMPLEMENTATION IN CLINICAL TRIAL DESIGN
Dr Michael Collins, Royal Adelaide Hospital

IMPLEMENTING EVIDENCE INTO GUIDELINES
Dr Emily See, Royal Melbourne Hospital

Thank you to Professor Carmel Hawley


CARI Session

PRIORITISATION OF GUIDELINE TOPICS
Brydee Cashmore, The University Of Sydney

REDUCING THE EVIDENCE-PRACTICE GAP – EXPANSION AND IMPLEMENTATION OF LIVING GUIDELINES
Dr David Tunnicliffe, The University Of Sydney

NEW TRIAL ENDPOINTS: CAN THE SLOPE OF eGFR DECLINE BE AN EFFECTIVE SURROGATE FOR CLINICAL KIDNEY EVENTS WHEN ACUTE eGFR CHANGES ARE NOT MEDIATED BY GLOMERULAR HAEMODYNAMICS?
Alexandra Gallagher
DIALYSIS ON COUNTRY
Dr Melanie Beacroft, Commonwealth Department of Health and Aged Care
COST EFFECTIVENESS OF PD IN COMPARISON TO HD
Professor KM Chow, Prince of Wales Hospital, Hong Kong
THE ACUTE, REVERSIBLE eGFR RESPONSE ASSOCIATED WITH FENOFIBRATE IS NOT HARMFUL: A POST HOC ANALYSIS FROM THE FIELD TRIAL
Alexandra Gallagher
1115 – 1130 ATRIAL FIBRILLATION IN ADVANCED CHRONIC KIDNEY DISEASE: A SURVEY OF CURRENT PRACTICE IN ANTICOAGULATION MANAGEMENT IN AUSTRALIA AND NEW ZEALAND (ANZ)
Mandy Law
RENAL NEDD4L AS A POTENTIAL NEW REGULATOR OF GLUCOSE HOMEOSTASIS AND DIABETIC NEPHROPATHY
Jantina Manning
1130 – 1145 THE IMPACT OF BASELINE FRAILTY, MULTIMORBIDITY, POLYPHARMACY AND HEALTH-RELATED QUALITY OF LIFE ON THE EFFECTS OF EMPAGLIFLOZIN: POST-HOC ANALYSES FROM THE EMPA-KIDNEY TRIAL
Daniel Vincent O’Hara
REPRODUCTIVE HEALTH IN WOMEN WITH KIDNEY DISEASE
Professor Shilpanjali Jesudason, Royal Adelaide Hospital
LESSONS LEARNED FROM THE FIRST 50 ENDOAVF CREATIONS
Associate Professor Chris Delaney, Flinders Medical Centre
FLOW PRIMARY RESULTS: A KIDNEY OUTCOMES TRIAL WITH ONCE-WEEKLY SEMAGLUTIDE IN PEOPLE WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Vlado Perkovic
1145 – 1200 INCREASING CKD DETECTION IN HIGH RISK COHORTS THROUGH PRACTICE DATA REVIEW, EDUCATION AND IMPLEMENTATION OF A STRUCTURED PRACTICE FRAMEWORK: THE CKD CLINICAL AUDIT
Breonny Robson
ASSOCIATION OF DIABETES AND CHRONIC KIDNEY DISEASE IN YOUNG ABORIGINAL AND NON-ABORIGINAL ADULTS USING LARGE-SCALE LINKED COHORT DATA IN AUSTRALIA: THE ARDAC STUDY
Jacqueline Stephens
1200 – 1215 DUAL INHIBITION OF COMPLEMENT C5a RECEPTOR 1 AND 2 IN DIABETIC KIDNEY DISEASE
Sih Min Tan
KIDNEY SUPPORTIVE CARE: MODELS OF CARE AROUND AUSTRALIA
Dr Frank Brennan (Paliative Care Physician), Kirsten Hepburn (Nephrologist), Laura Lunardi (Nephrology Nurse Practitioner)Sara Rendo (Palliative Care Physician)
WHO BENEFITS THE MOST FROM SGLT2 INHIBITORS? INSIGHTS FROM EMPA-KIDNEY
Professor Richard Haynes, University of Oxford
HNRNPF OVEREXPRESSION EXTENSIVELY REGULATES EXPRESSION AND ALTERNATIVE SPLICING OF TARGET GENES ASSOCIATED WITH THE PROGRESSION OF DIABETIC KIDNEY DISEASE
Lan Wang
1215 – 1230 Panel Discussion with all speakers LONG TERM RISK OF KIDNEY FAILURE FOLLOWING CARDIAC SURGERY: A NATIONAL DATA LINKAGE STUDY
Dominic Keuskamp
Mini Oral buffer 
1230 – 1330 Lunch, Exhibition, Poster Viewing | Exhibition Area
1330 – 1500 PLENARY #5: Awards, Handover & Closing
Room HALL D
Chair Professor Rathika Krishnasamy
1330 – 1430 Jaquot Award
Research Establishment Presentation – Dr Melanie Wyld, Renal and Transplant Physician, University of Sydney & Westmead Hospital
Research Establishment PresentationDr Michael Collins, Senior Consultant Nephrologist, University of Adelaide & Royal Adelaide Hospital
TJ Neale award – Professor Robert Walker
A SERENDIPITOUS JOURNEY AS A CLINICAL SCIENTIST
1430 – 1500 President’s Wrap, Handover to 2025 & Close 
1500 ASM Concludes
1530 – 1800 Interventional Nephrology Workshop (Day 1)
Categories